CD4 T-CELL SUBSETS RESPOND DIFFERENTLY TO LATENCY REVERSAL AGENTS

Farydak (panobinostat) - Novartis

JQ-1 - Roche

bryostatin 1 (NSC 339555) - Neurotrope BioScience

Istodax (romidepsin) - Celgene, Astellas

http://www.croiconference.org/sessions/cd4-t-cell-subsets-respond-differently-latency-reversal-agents

Judith Grau-Expósito1; Laura Luque-Ballesteros1; Adrià Curran2; Joaquin Burgos2; Esteban Ribera2; Ariadna Torrella2; Bibiana Planas2; Rosa Badía2; Vicenç Falcó2; María J. Buzón1

Mar 8, 2019